Hyperkalemia is a condition characterized by elevated serum potassium levels above 5 mEq/L, which can cause dangerous cardiac arrhythmias and potentially death. It requires prompt recognition and management to prevent cardiac complications.
Key points for clinical pharmacists:
- Etiology: Common causes include impaired renal excretion (e.g., chronic kidney disease), medications that reduce potassium elimination or shift potassium extracellularly (e.g., ACE inhibitors, potassium-sparing diuretics), cell lysis, and metabolic acidosis.
- Clinical significance: Elevated potassium affects cardiac membrane potentials, increasing the risk of life-threatening arrhythmias. ECG changes such as peaked T waves can indicate severity.
- Acute management:
- Stabilize cardiac membranes: IV calcium gluconate or calcium chloride to reduce arrhythmia risk without lowering potassium levels.
- Shift potassium intracellularly: Use insulin (with glucose to prevent hypoglycemia) or beta-2 adrenergic agonists (e.g., albuterol).
- Remove potassium from the body: Sodium polystyrene sulfonate, newer potassium binders (sodium zirconium cyclosilicate or patiromer), loop diuretics, or dialysis if urgent removal is needed.
- Medication review: Identify and discontinue or adjust contributing drugs.
- Monitoring: Frequent potassium and ECG monitoring until stabilized.
- Pharmacist roles:
- Provide guidance on medication adjustments.
- Assist in selecting appropriate treatment options.
- Educate patients about diet and medication adherence to prevent hyperkalemia.
- Collaborate with healthcare teams to maintain guideline-directed medical therapy safely despite elevated potassium.
In summary, hyperkalemia management involves immediate cardiac protection, intracellular potassium redistribution, and elimination strategies. Pharmacists are integral in optimizing therapy, preventing recurrence, and ensuring safe medication use
Links